BestJGArramLAhmedN, et al. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): protocol for a randomized controlled trial. Int J Stroke2022; 17: 583–589.
2.
LiSGuHQFengB, et al. RhPro-UK in acute ischemic stroke within 4.5 h of stroke onset trial-2 (the PROST-2 study): rationale and design of a multicenter, prospective, randomized, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial. Int J Stroke2024; 19: 1182–1187.
3.
WerringDDehbiH-MAhmedN, et al. Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial on behalf of the OPTIMAS investigators. Lancet2024; 404: 1731–1741.
4.
CampbellBC.Hyperacute ischemic stroke care: current treatment and future directions. Int J Stroke2024; 19: 718–726.
5.
ShahjoueiSBavarsad ShahripourRDumitrascuOM.Thrombolysis for central retinal artery occlusion: an individual participant-level meta-analysis. Int J Stroke2024; 19: 29–39.
6.
PoliSGrohmannCWenzelDA, et al. Early REperfusion therapy with intravenous alteplase for recovery of VISION in acute central retinal artery occlusion (REVISION): study protocol of a phase III trial. Int J Stroke2024; 19: 823–829.
7.
ElsherifSLegereBMohamedA, et al. Beyond conventional imaging: a systematic review and meta-analysis assessing the impact of computed tomography perfusion on ischemic stroke outcomes in the late-window. Int J Stroke. Epub ahead of print 7 October 2024. DOI: 10.1177/17474930241292915.
8.
YedavalliVSalimHMusmarB, et al. Pretreatment predictors of very poor clinical outcomes in medium vessel occlusion stroke patients treated with mechanical thrombectomy. Int J Stroke2024; 19: 1123–1133.
9.
JungJWKimKHYunJ, et al. Impact of intensive blood pressure lowering after multiple-attempt endovascular thrombectomy: a secondary analysis of the OPTIMAL-BP trial. Int J Stroke2024; 19: 1134–1146.
10.
HeitkampCHeitkampAWinkelmeierL, et al. Predictors of futile recanalization in ischemic stroke patients with low baseline NIHSS. Int J Stroke2024; 19: 1102–1112.
